Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 – 2032

Absorbable Nasal Implant Devices Market Size

Absorbable Nasal Implant Devices Market size surpassed USD 581 million in 2022 and is expected to grow at 7% CAGR from 2023 to 2032. The increasing prevalence of nasal congestions caused by a variety of factors such as allergies, infections, or structural abnormalities are projected to propel the industry growth.
 

The American College of Allergy, Asthma & Immunology, in 2021, estimates that the nasal congestion is a common health complaint, with an estimated 20 million individuals experience this condition every year in the U.S. Also, the estimates state that up to 30% of adults and 40% of children experience nasal congestion due to allergies. Moreover, the technological advancements in the development of nasal absorbable implants with lowered complications including irritation and other extremities is contributing to the market growth.
 

Absorbable nasal implant devices are medical devices designed to provide temporary support and drug delivery to the nasal cavity. They are typically made of materials that can be absorbed by the body over time, eliminating the need for removal surgery. These devices can be used to treat a variety of nasal conditions such as nasal valve collapse, septal deviation, or inferior turbinate hypertrophy. They are used for drug delivery, releasing medications such as corticosteroids or antibiotics directly to the nasal cavity to treat inflammation or infection.
 

However, the lack of product awareness among the populace regarding nasal implants, particularly absorbable nasal implant devices may impede the market growth. Many people are unaware that these devices exist as a treatment option for nasal conditions such as nasal valve collapse or septal deviation. This lack of awareness is owing to the limited use and knowledge, as these devices are relatively new & are not widely adopted in clinical practice.
 

COVID-19 Impact

Nation-wide lockdowns, and emergencies were imposed in various countries and maintaining crucial medical resources was given priority owing to COVID-19. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations. These developments enforced delays or suspension in the routine care by several healthcare settings, including nasal surgery practice. Certain surgical societies published recommendations regarding postponing implantation procedures, further negatively impacting the nasal surgery practice at ambulatory surgical centers and hospitals in the early 2020,
 

Absorbable Nasal Implant Devices Market Trends

The increasing prevalence of nasal congestion and the surging number of nasal reconstruction surgeries is escalating the demand for absorbable nasal implants. Nasal congestion refers to obstruction and reduced airflow in the nasal cavity in clinical practice. Multiple conditions are related with congestion that comprises nasal polyposis, obstructive sleep apnea, and anatomic variation. These conditions significantly impair quality of life, congestion leads to reduced daytime productivity and lower night-time sleep time & quality.
 

As per the National Centers for Biotechnology Information (NCBI) article, in 2019, rhinosinusitis impacts tens of millions of Americans, further leading to nearly USD 6 billion in overall health care expenditures. Statistics indicate that the allergic rhinitis prevalence varies significantly, from 10% to as high as 40%. Overall, the approximate prevalence rate is around 10% to 20% of the global population, with the prevalence of allergic rhinitis increasing since the last 2 to 3 decades. Thus, the high prevalence of these conditions is promoting share.
 

In addition, considering the high prevalence coupled substantial economic & social burden of this condition, there continues to be a notable unmet clinical need for effective therapeutic alternatives for these conditions. This development further offers a market penetration and business expansion opportunity for the key players. As a result, the growing number for surgical procedures, the rising prevalence of nasal congestion along with associated conditions, and under-penetrated market opportunity is supporting business growth.  
 

Absorbable Nasal Implant Devices Market Analysis

The drug eluting absorbable nasal implants segment accounted for more than 62% revenue share of the global absorbable nasal implant devices market in 2022. This growth is primarily attributed to the higher preference and adoption of drug eluting absorbable nasal implants. These implants release a broad range of medications & provide more targeted and effective treatment while minimizing systemic side effects. Thus, the use of drug-eluting absorbable nasal implants is a promising alternative treatment for various nasal conditions, and ongoing research & development augment the market expansion.
 

The polymer segment of absorbable nasal implant devices market is likely to observe 7.2% CAGR from 2023 to 2032. Polymers are used in absorbable nasal implants to gradually degrade and absorb into the body over time, eliminating the need for a second surgery to remove the implant. These materials are designed to have specific mechanical and biological properties, allowing for customization of the implant to the individual patient's needs and their non-toxic nature helps in eliminating the risk of potential adverse reactions. Other advantages include reduced inflammation, reduced risk of infection, and increased patient comfort. Thus, the above-mentioned benefits associated with the polymer material is anticipated to drive the segmental revenue growth.
 

The absorbable nasal implant devices market revenue from hospitals segment crossed USD 293 million in 2022. This significant segment growth is majorly attributed to the surging patient preference for hospitals owing to the availability of advanced equipment and professionals delivering quality treatment. As per recent research, studies performed on patients in hospitals deliver an accurate diagnosis that allows precise & effective treatment, thereby delivering optimal treatment outcomes along with affordability.
 

Similarly, the availability of a broad range of nasal conditions and related co-morbidities treatment incorporating advanced devices caters to the patient population is expected to proliferate the segmental revenue positively. Thus, the high-quality services and growing patient preference for hospitals is estimated to boost the market statistics.
 

The U.S. dominated the North America absorbable nasal implant devices market with a majority market share in 2022 and is predicted to reach over USD 415 million by 2032.  This dominant market growth is primarily owing to several variables including the high disease burden of nasal conditions, rising number of nasal reconstruction surgeries, and rise in awareness regarding absorbable nasal implants.
 

For instance, as per the recent survey, in 2021, around 1 in 4 Americans witness nasal congestion on daily basis and about 85% stated that this condition negatively impacts their daily activities. Additionally, the presence of major players including Stryker Corporation, Smith & Nephew, Johnson and Johnson, etc., the heavy investments in R&D for effective therapeutic options along with reduced complications of surgical techniques are fuelling the regional market growth.
 

Absorbable Nasal Implant Devices Market Share

Some of the major players operating in the absorbable nasal implant devices market are:

• Smith and Nephew plc
• Intersect ENT Inc
• Spirox Inc (Entellus Medical)
• Stryker Corporation
• Johnson & Johnson
   

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These participants focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Absorbable Nasal Implant Devices Industry in News:

• In March 2021, Intersect ENT received the U.S. FDA approval for its Propel Contour sinus implant, which is a mometasone furoate-eluting implant designed to improve outcomes for patients undergoing sinus surgery. This product launch helped the company to introduce innovative products, further offering a competitive edge over its competitors.
   
• In February 2019, Spirox launched its Latera Absorbable Nasal Implant that is indicated & designed to treat nasal obstruction due to nasal valve collapse associated with nasal congestion or allergic rhinitis. The implant is made of an absorbable polymer material and is placed in the nasal sidewall. This product launch helped the company to strengthen its product portfolio across the global market.
   

This absorbable nasal implant devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product Type

• Drug Eluting Absorbable Nasal Implants 
  • Corticosteroids Eluting Implants
  • Antibiotics Eluting Implants
  • Others
• Non-Drug Eluting Nasal Implants            

By Material Type

• Polymer
• Carboxy Methyl Cellulose (CMC)
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey